X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (10382) 10382
Newsletter (113) 113
Newspaper Article (8) 8
Publication (6) 6
Magazine Article (5) 5
Book Review (2) 2
Book Chapter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (9535) 9535
female (6574) 6574
male (6470) 6470
leucovorin - administration & dosage (6115) 6115
middle aged (5934) 5934
oncology (5837) 5837
antineoplastic combined chemotherapy protocols - therapeutic use (5826) 5826
aged (5458) 5458
fluorouracil - administration & dosage (5441) 5441
adult (4659) 4659
leucovorin (3970) 3970
chemotherapy (3577) 3577
fluorouracil (3454) 3454
colorectal neoplasms - drug therapy (3198) 3198
treatment outcome (2631) 2631
antineoplastic combined chemotherapy protocols - adverse effects (2583) 2583
cancer (2439) 2439
colorectal cancer (2409) 2409
organoplatinum compounds - administration & dosage (2243) 2243
antineoplastic combined chemotherapy protocols - administration & dosage (2224) 2224
oxaliplatin (2208) 2208
colorectal neoplasms - pathology (2074) 2074
5-fluorouracil (2011) 2011
camptothecin - analogs & derivatives (1856) 1856
drug administration schedule (1778) 1778
fluorouracil - adverse effects (1602) 1602
camptothecin - administration & dosage (1584) 1584
aged, 80 and over (1493) 1493
leucovorin - therapeutic use (1492) 1492
irinotecan (1443) 1443
neoplasm staging (1410) 1410
adenocarcinoma - drug therapy (1375) 1375
disease-free survival (1360) 1360
methotrexate - administration & dosage (1351) 1351
leucovorin - adverse effects (1331) 1331
survival rate (1285) 1285
fluorouracil - therapeutic use (1280) 1280
bevacizumab (1217) 1217
therapy (1170) 1170
liver neoplasms - secondary (1154) 1154
neoplasm metastasis (1125) 1125
carcinoma (1107) 1107
survival analysis (1088) 1088
prognosis (1080) 1080
chemotherapy, adjuvant (1074) 1074
trial (1063) 1063
combined modality therapy (1061) 1061
1st-line treatment (1036) 1036
retrospective studies (1034) 1034
surgery (1030) 1030
metastasis (1028) 1028
deoxycytidine - analogs & derivatives (1018) 1018
capecitabine (1017) 1017
care and treatment (1012) 1012
pharmacology & pharmacy (1010) 1010
survival (1010) 1010
liver neoplasms - drug therapy (960) 960
infusions, intravenous (905) 905
medicine & public health (892) 892
folinic acid (883) 883
cisplatin - administration & dosage (875) 875
colonic neoplasms - drug therapy (857) 857
colorectal neoplasms - mortality (849) 849
antimetabolites, antineoplastic - administration & dosage (835) 835
deoxycytidine - administration & dosage (829) 829
organoplatinum compounds - adverse effects (817) 817
follow-up studies (793) 793
combination (770) 770
research (761) 761
dose-response relationship, drug (732) 732
stomach neoplasms - drug therapy (677) 677
prospective studies (673) 673
antineoplastic agents - administration & dosage (666) 666
fluorouracil - analogs & derivatives (664) 664
time factors (654) 654
randomized-trial (647) 647
organoplatinum compounds - therapeutic use (644) 644
cisplatin (640) 640
administration, oral (612) 612
adenocarcinoma - pathology (611) 611
phase-ii (607) 607
rectal neoplasms - drug therapy (598) 598
drug therapy (588) 588
colorectal-cancer (582) 582
adolescent (576) 576
tegafur - administration & dosage (574) 574
cetuximab (573) 573
metastatic colorectal-cancer (569) 569
colonic neoplasms - pathology (563) 563
drug therapy, combination (561) 561
animals (557) 557
antineoplastic agents - therapeutic use (555) 555
toxicity (539) 539
adenocarcinoma - secondary (528) 528
analysis (523) 523
antibodies, monoclonal - administration & dosage (523) 523
doxorubicin - administration & dosage (509) 509
rectal neoplasms - pathology (508) 508
antibodies, monoclonal, humanized (507) 507
methotrexate (507) 507
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9601) 9601
Japanese (677) 677
German (130) 130
French (126) 126
Chinese (91) 91
Italian (59) 59
Spanish (45) 45
Russian (26) 26
Hungarian (15) 15
Dutch (7) 7
Polish (7) 7
Danish (6) 6
Czech (5) 5
Korean (5) 5
Norwegian (3) 3
Hebrew (2) 2
Lithuanian (2) 2
Serbian (2) 2
Arabic (1) 1
Bulgarian (1) 1
Finnish (1) 1
Persian (1) 1
Portuguese (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane library, ISSN 1469-493X, 06/2016, Volume 2019, Issue 9, p. CD007102
Background This is the second update of a Cochrane review that was first published in 2009, Issue 1. Gestational trophoblastic neoplasia (GTN) is a rare but... 
Trophoblastic | Drug Administration Schedule | Antineoplastic Agents | Risk | Leucovorin | Dactinomycin | Gestational trophoblastic neoplasia | Randomized Controlled Trials as Topic | Gynaecology | Gynaecological | MISCELLANEOUS GYNAECOLOGICAL CANCER TOPICS | Gestational Trophoblastic Disease | Vitamin B Complex | Case‐Control Studies | Methotrexate | Medicine General & Introductory Medical Sciences | Cohort Studies | Cancer | Vitamin B Complex [administration & dosage] | Methotrexate [administration & dosage; adverse effects] | Humans | Antineoplastic Agents [administration & dosage; adverse effects] | FOLINIC ACID | Case-Control Studies | Leucovorin [administration & dosage] | MEDICINE, GENERAL & INTERNAL | CITROVORUM FACTOR RESCUE | PHASE-II TRIAL | Dactinomycin [administration & dosage; adverse effects] | WEEKLY INTRAMUSCULAR METHOTREXATE | Gestational Trophoblastic Disease [drug therapy] | Female | LOW-DOSE METHOTREXATE | SINGLE-AGENT METHOTREXATE | 5-DAY METHOTREXATE | Pregnancy | DISEASE | ORAL ETOPOSIDE | PULSE ACTINOMYCIN-D | Leucovorin - administration & dosage | Dactinomycin - administration & dosage | Antineoplastic Agents - administration & dosage | Vitamin B Complex - administration & dosage | Methotrexate - adverse effects | Antineoplastic Agents - adverse effects | Dactinomycin - adverse effects | Methotrexate - administration & dosage | Gestational Trophoblastic Disease - drug therapy
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 5, pp. 499 - 508
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 388, Issue 10039, pp. 73 - 85
Summary Pancreatic cancer is a highly lethal disease, for which mortality closely parallels incidence. Most patients with pancreatic cancer remain asymptomatic... 
Internal Medicine | PHASE-III TRIAL | ADJUVANT CHEMOTHERAPY | MEDICINE, GENERAL & INTERNAL | DIFFERENTIAL-DIAGNOSIS | FINE-NEEDLE-ASPIRATION | INCREASED RISK | AUTOIMMUNE PANCREATITIS | EARLY MANIFESTATIONS | CLASSIFICATION-SYSTEM | PREOPERATIVE EVALUATION | INTRAEPITHELIAL NEOPLASIA | Leucovorin - administration & dosage | Endosonography | Pancreatic Neoplasms - diagnosis | Proto-Oncogene Proteins p21(ras) - genetics | Humans | Tumor Suppressor Protein p53 - genetics | Carcinoembryonic Antigen - metabolism | Carcinoma, Pancreatic Ductal - genetics | Neoplasms, Cystic, Mucinous, and Serous - genetics | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Smad4 Protein - genetics | Carcinoma, Pancreatic Ductal - diagnosis | Camptothecin - administration & dosage | Paclitaxel - administration & dosage | Endoscopic Ultrasound-Guided Fine Needle Aspiration | Camptothecin - analogs & derivatives | Deoxycytidine - administration & dosage | Pancreatectomy | Albumins - administration & dosage | Pancreatic Neoplasms - genetics | Carcinoma, Pancreatic Ductal - therapy | Genes, p16 | CA-19-9 Antigen - metabolism | Neoplasms, Cystic, Mucinous, and Serous - therapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Neoplasms, Cystic, Mucinous, and Serous - diagnosis | Deoxycytidine - analogs & derivatives | Pancreatic Neoplasms - therapy | Medical colleges | Ultrasound imaging | Oncology, Experimental | Mortality | Japan | Pancreatitis | Adjuvant treatment | Leucovorin | Research | Pancreatic cancer | Diagnosis | Tumor proteins | Health aspects | Cancer | Pathology | Chemotherapy | Medical prognosis | Metastasis | Health risk assessment | Cancer therapies | Tumors
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1306 - 1315
Summary Background In the TRIBE study, FOLFOXIRI (fluorouracil, leucovorin, oxaliplatin, and irinotecan) plus bevacizumab significantly improved... 
Hematology, Oncology and Palliative Medicine | TRIAL | CETUXIMAB | SURROGATE | LEUCOVORIN | ONCOLOGY | END-POINT | PROGRESSION-FREE SURVIVAL | RAS MUTATIONS | GUIDELINES | KRAS | FLUOROURACIL | Leucovorin - administration & dosage | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Bevacizumab - therapeutic use | Bevacizumab - adverse effects | Colorectal Neoplasms - genetics | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Angiogenesis Inhibitors - administration & dosage | Neoplasm Metastasis | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Time Factors | DNA Mutational Analysis | Colorectal Neoplasms - drug therapy | Angiogenesis Inhibitors - therapeutic use | Camptothecin - administration & dosage | Female | Angiogenesis Inhibitors - adverse effects | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Bevacizumab - administration & dosage | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Proto-Oncogene Proteins - genetics | Treatment Outcome | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Intention to Treat Analysis | Italy | Aged | Infusions, Intravenous | Mutation | Colorectal Neoplasms - pathology | Antimitotic agents | Cancer patients | Care and treatment | Patient outcomes | Analysis | Colorectal cancer | Leucovorin | Metastasis | Antineoplastic agents
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 13, pp. 1278 - 1286
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2019, Volume 393, Issue 10184, pp. 1948 - 1957
Docetaxel-based chemotherapy is effective in metastatic gastric and gastro-oesophageal junction adenocarcinoma. This study reports on the safety and efficacy... 
SURGERY | REGRESSION | MEDICINE, GENERAL & INTERNAL | MULTICENTER | RESECTION | CHEMORADIOTHERAPY | OPEN-LABEL | ESOPHAGEAL | CANCER | STOMACH | Capecitabine - administration & dosage | Leucovorin - administration & dosage | Adenocarcinoma - pathology | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Male | Oxaliplatin - therapeutic use | Stomach Neoplasms - pathology | Cisplatin - administration & dosage | Fluorouracil - therapeutic use | Docetaxel - administration & dosage | Fluorouracil - administration & dosage | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Oxaliplatin - administration & dosage | Administration, Oral | Esophagogastric Junction - pathology | Treatment Outcome | Capecitabine - therapeutic use | Stomach Neoplasms - drug therapy | Adenocarcinoma - drug therapy | Disease-Free Survival | Digestive System Surgical Procedures | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Docetaxel - therapeutic use | Aged | Neoplasm Staging | Adenocarcinoma | Anthracyclines | Chemotherapy | Leucovorin | Product development | Esophageal cancer | Cancer | Intravenous administration | Control methods | Toxicity | Clinical trials | Oncology | Metastasis | Cancer therapies | Stomach cancer | Evidence-based medicine | Metastases | Confidence intervals | Infusion | Oxaliplatin | Motivation | Surgery | Intravenous infusion | Epirubicin | Medical research | Survival | Patients | Cisplatin | Esophagus | Interactive systems | Medical prognosis | Tumors | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 9, pp. 853 - 860
Summary Background Fluorouracil and folinic acid with either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) are widely used as first-line or second-line... 
Hematology, Oncology and Palliative Medicine | TRIAL | CAPECITABINE | 1ST-LINE TREATMENT | INFUSIONAL FLUOROURACIL/LEUCOVORIN | LEUCOVORIN | THERAPY | ONCOLOGY | 5-FLUOROURACIL/FOLINIC ACID | FLUOROPYRIMIDINE | OXALIPLATIN | FAILURE | Prodrugs - administration & dosage | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Fluorouracil - analogs & derivatives | Tegafur - adverse effects | Kaplan-Meier Estimate | Oxonic Acid - administration & dosage | Adenocarcinoma - drug therapy | Oxonic Acid - adverse effects | Disease-Free Survival | Prodrugs - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Drug Combinations | Adenocarcinoma - mortality | Medical colleges | Chemotherapy | Oncology, Experimental | Colorectal cancer | Leucovorin | Research | Metastasis | Cancer | Fluorouracil | Analysis
Journal Article
Cochrane database of systematic reviews (Online), ISSN 1469-493X, 2012, Volume 2012, Issue 7, p. CD007102
Journal Article
Annals of oncology, ISSN 0923-7534, 2009, Volume 20, Issue 11, pp. 1842 - 1847
Background: Bevacizumab significantly improves survival when added to chemotherapy for metastatic colorectal cancer (mCRC). The Bevacizumab Expanded Access... 
Expanded access study | Chemotherapy | First line | mCRC | Metastatic colorectal cancer | Bevacizumab | expanded access study | LEUCOVORIN | PHASE-II | first line | OXALIPLATIN | FLUOROURACIL | COMBINATION | chemotherapy | THERAPY | ONCOLOGY | bevacizumab | metastatic colorectal cancer | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Young Adult | Antibodies, Monoclonal, Humanized | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Camptothecin - administration & dosage | Deoxycytidine - adverse effects | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Fluorouracil - analogs & derivatives | Deoxycytidine - administration & dosage | Kaplan-Meier Estimate | Disease-Free Survival | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Deoxycytidine - analogs & derivatives | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article